Repurposing Itraconazole as a Treatment for Advanced Prostate Cancer: A Noncomparative Randomized Phase II Trial in Men With Metastatic Castration-Resistant Prostate CancerEmmanuel S. Antonarakis, Michael A. Carducci, Amanda L. Blackford et al.|The Oncologist|2013Cited by 178
Tasquinimod Is an Allosteric Modulator of HDAC4 Survival Signaling within the Compromised Cancer MicroenvironmentJohn T. Isaacs, Tomas Leanderson, Lizamma Antony et al.|Cancer Research|2012Cited by 113
Selective inhibitors of nuclear export (SINE) as novel therapeutics for prostate cancerJanet Mendonca, Sushant K. Kachhap|Oncotarget|2014Cited by 63
Combining the pan‐aurora kinase inhibitor <scp>AMG</scp> 900 with histone deacetylase inhibitors enhances antitumor activity in prostate cancerChanning J. Paller, Sushant K. Kachhap|Cancer Medicine|2014Cited by 30